PUBLISHER: TechNavio | PRODUCT CODE: 2078553
PUBLISHER: TechNavio | PRODUCT CODE: 2078553
Global Bioreactors Market 2026-2030
The global bioreactors market is forecasted to grow by USD 3326.4 mn during 2025-2030, accelerating at a CAGR of 7.6% during the forecast period. The report on the global bioreactors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by accelerating demand for biopharmaceuticals and biosimilars, rapid adoption of single-use bioreactor technologies for operational flexibility, expansion of cell and gene therapy manufacturing and personalized medicine.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 7% |
| CAGR | 7.6% |
| Incremental Value | $3326.4 mn |
Technavio's global bioreactors market is segmented as below:
By End-User
- Biopharmaceutical
- Research institutes
- CROs
By Type
- Automated
- Manual
By Application
- Cell culture
- Vaccine production
- Stem-cell research
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the integration of ai and digital twin technology in bioprocessing operations as one of the prime reasons driving the global bioreactors market growth during the next few years. Also, proliferation of continuous bioprocessing and high-density perfusion systems and expansion of bioreactor applications into cellular agriculture and alternative protein production will lead to sizable demand in the market.
The report on the global bioreactors market covers the following areas:
- Global bioreactors market sizing
- Global bioreactors market forecast
- Global bioreactors market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global bioreactors market vendors that include Adolf Kuhner AG, BBI Biotech GmbH, Bio Rad Laboratories Inc., Bioengineering AG, Bionet Co. Ltd, Cellexus Ltd, CerCell ApS, Cytiva, Eppendorf SE, GEA Group AG, IKA Werke GmbH and Co. KG, Lonza Group Ltd., Meissner Filtration Products, Merck KGaA, Novartis AG, PBS Biotech Inc., Sartorius AG, Thermo Fisher Scientific Inc., VWR International LLC, ZETA. Also, the global bioreactors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Bioreactors Market 2020 - 2024
- Historic Market Size - Data Table on Global Bioreactors Market 2020 - 2024 ($ million)
- 5.2 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- 5.3 Type segment analysis 2020 - 2024
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
- 5.4 Application segment analysis 2020 - 2024
- Historic Market Size - Application Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on global bioreactors market
- 6.2 Impact of geopolitical conflicts on global bioreactors market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by End-user
- 8.1 Market segments
- 8.2 Comparison by End-user
- 8.3 Biopharmaceutical - Market size and forecast 2025-2030
- 8.4 Research institutes - Market size and forecast 2025-2030
- 8.5 CROs - Market size and forecast 2025-2030
- 8.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
9 Market Segmentation by Type
- 9.1 Market segments
- 9.2 Comparison by Type
- 9.3 Automated - Market size and forecast 2025-2030
- 9.4 Manual - Market size and forecast 2025-2030
- 9.5 Market opportunity by Type
- Market opportunity by Type ($ million)
10 Market Segmentation by Application
- 10.1 Market segments
- 10.2 Comparison by Application
- 10.3 Cell culture - Market size and forecast 2025-2030
- 10.4 Vaccine production - Market size and forecast 2025-2030
- 10.5 Stem-cell research - Market size and forecast 2025-2030
- 10.6 Market opportunity by Application
- Market opportunity by Application ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 Japan - Market size and forecast 2025-2030
- 12.5.3 India - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Indonesia - Market size and forecast 2025-2030
- 12.5.6 Thailand - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 UAE - Market size and forecast 2025-2030
- 12.6.4 Turkey - Market size and forecast 2025-2030
- 12.6.5 Argentina - Market size and forecast 2025-2030
- 12.6.6 South Africa - Market size and forecast 2025-2030
- 12.6.7 Colombia - Market size and forecast 2025-2030
- 12.6.8 Israel - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Accelerating demand for biopharmaceuticals and biosimilars
- Rapid adoption of single-use bioreactor technologies for operational flexibility
- Expansion of cell and gene therapy manufacturing and personalized medicine
- 13.2 Market challenges
- High initial capital expenditure and sustained operational costs
- Stringent regulatory standards and validation complexities
- Technical barriers in large-scale production and supply chain fragility
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Integration of AI and digital twin technology in bioprocessing operations
- Proliferation of continuous bioprocessing and high-density perfusion systems
- Expansion of bioreactor applications into cellular agriculture and alternative protein production
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 BBI Biotech GmbH
- BBI Biotech GmbH - Overview
- BBI Biotech GmbH - Product / Service
- BBI Biotech GmbH - Key offerings
- SWOT
- 15.5 Bio Rad Laboratories Inc.
- Bio Rad Laboratories Inc. - Overview
- Bio Rad Laboratories Inc. - Business segments
- Bio Rad Laboratories Inc. - Key news
- Bio Rad Laboratories Inc. - Key offerings
- Bio Rad Laboratories Inc. - Segment focus
- SWOT
- 15.6 Bionet Co. Ltd
- Bionet Co. Ltd - Overview
- Bionet Co. Ltd - Product / Service
- Bionet Co. Ltd - Key offerings
- SWOT
- 15.7 Cytiva
- Cytiva - Overview
- Cytiva - Product / Service
- Cytiva - Key offerings
- SWOT
- 15.8 Eppendorf SE
- Eppendorf SE - Overview
- Eppendorf SE - Product / Service
- Eppendorf SE - Key offerings
- SWOT
- 15.9 GEA Group AG
- GEA Group AG - Overview
- GEA Group AG - Business segments
- GEA Group AG - Key news
- GEA Group AG - Key offerings
- GEA Group AG - Segment focus
- SWOT
- 15.10 IKA Werke GmbH and Co. KG
- IKA Werke GmbH and Co. KG - Overview
- IKA Werke GmbH and Co. KG - Product / Service
- IKA Werke GmbH and Co. KG - Key offerings
- SWOT
- 15.11 Lonza Group Ltd.
- Lonza Group Ltd. - Overview
- Lonza Group Ltd. - Business segments
- Lonza Group Ltd. - Key news
- Lonza Group Ltd. - Key offerings
- Lonza Group Ltd. - Segment focus
- SWOT
- 15.12 Meissner Filtration Products
- Meissner Filtration Products - Overview
- Meissner Filtration Products - Product / Service
- Meissner Filtration Products - Key offerings
- SWOT
- 15.13 Merck KGaA
- Merck KGaA - Overview
- Merck KGaA - Business segments
- Merck KGaA - Key news
- Merck KGaA - Key offerings
- Merck KGaA - Segment focus
- SWOT
- 15.14 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- 15.15 Sartorius AG
- Sartorius AG - Overview
- Sartorius AG - Business segments
- Sartorius AG - Key offerings
- Sartorius AG - Segment focus
- SWOT
- 15.16 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
- 15.17 VWR International LLC
- VWR International LLC - Overview
- VWR International LLC - Product / Service
- VWR International LLC - Key offerings
- SWOT
- 15.18 ZETA
- ZETA - Overview
- ZETA - Product / Service
- ZETA - Key offerings
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
